Substituted imidazo[1,2-B]pyridazines

US8987273B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Hartmut Rehwinkel · Berlin, DE
• Andrea Hägebarth · Berlin, DE
• Oliver Politz · Panketal, DE
• Roland Neuhaus · Berlin, DE
• Ulf Bömer · Glienicke, DE

Key dates

• Filing date: Jul 27, 2011
• Grant date: Mar 24, 2015
• Expiry date: Jul 27, 2031

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to imidazo[1,2-b]pyridazines of general formula (I) a process for their manufacture and their use for the treatment of benign and malignant neoplasia.